AN2 Therapeutics, Inc.'s market cap is currently $33.76M. The company's EPS TTM is $-2.037; its P/E ratio is ―; AN2 Therapeutics, Inc. is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ -77.00K	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -69.64M	$ -42.26M	$ -21.57M	$ -7.28M	$ -5.18M
EBITDA	$ 4.90M	$ -42.26M	$ 0.00	$ -6.32M	$ 0.00
Net Income	$ -64.73M	$ -41.47M	$ -21.47M	$ -13.60M	$ -5.63M
Balance Sheet
Cash & Short-Term Investments	$ 107.30M	$ 96.06M	$ 58.55M	$ 4.07M	$ 5.60M
Total Assets	$ 138.74M	$ 102.56M	$ 65.32M	$ 4.23M	$ 5.70M
Total Debt	$ 0.00	$ 53.00K	$ 0.00	$ 0.00	$ 728.00K
Net Debt	$ -15.65M	$ -27.17M	$ -12.10M	$ -4.07M	$ -4.87M
Total Liabilities	$ 14.04M	$ 7.19M	$ 112.73M	$ 24.55M	$ 887.00K
Stockholders' Equity	$ 124.70M	$ 95.37M	$ -47.41M	$ -20.32M	$ 4.81M
Cash Flow
Free Cash Flow	$ -53.29M	$ -33.46M	$ -20.48M	$ -5.36M	$ -2.49M
Operating Cash Flow	$ -53.29M	$ -33.46M	$ -20.48M	$ -5.36M	$ -2.49M
Investing Cash Flow	$ -43.28M	$ -21.77M	$ -50.02M	$ 0.00	$ 0.00
Financing Cash Flow	$ 84.99M	$ 70.36M	$ 78.53M	$ 3.84M	$ 8.08M

Currency in USD

AN2 Therapeutics, Inc. Earnings and Revenue History

Income Statement >

AN2 Therapeutics, Inc. Debt to Assets

Balance Sheet >

AN2 Therapeutics, Inc. Cash Flow

Cash Flow >

AN2 Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing